ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,974.07
0.73%
Dow Jones
42,906.95
0.16%
US Dollar vs MXN
20.1852
0.00%
Brent Oil
72.69
-0.01%
Bitcoin
94,272.19
-0.44%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Metagenomi Inc (MGX) Cotización

Metagenomi Inc

Metagenomi Inc (MGX)

Mount Gibson Iron Limited
4.01
-0.04
(-0.99%)
Al cierre: 23 Diciembre 3:00PM
Delayed by 15 minutes
4.07
0.06
( 1.50% )
Fuera de horario: 6:55PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
4.07
Postura de Compra
4.00
Postura de Venta
4.07
Volume Operado de la Acción
1,331,185
3.825 Rango del Día 4.40
1.61 Rango de 52 semanas 12.74
Capitalización de Mercado [m]
152.315M
Precio Anterior
4.05
Precio de Apertura
4.11
Hora
25
@
4.07
Última hora de negociación
Volumen financiero
US$ 5,482,212
Precio Promedio Ponderado
4.1183
Volumen promedio (3 m)
1,843,654
Acciones en circulación
37,423,917
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.19
Beneficio por acción (BPA)
-1.82
turnover
44.76M
Beneficio neto
-68.26M

Acerca de Metagenomi Inc

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.metagenomi.co
Sede
Wilmington, Delaware, USA
Fundado
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was US$4.05. Over the last year, Metagenomi shares have traded in a share price range of US$ 1.61 to US$ 12.74.

Metagenomi currently has 37,423,917 shares in issue. The market capitalisation of Metagenomi is US$151.57 million. Metagenomi has a price to earnings ratio (PE ratio) of -2.19.

MGX Últimas noticias

Más noticias

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...

11 Diciembre 2024
GlobeNewswire Inc.

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen months of follow up MGX-001 bioengineered FVIII...

09 Diciembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

06 Diciembre 2024
Edgar (US Regulatory)

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

22 Noviembre 2024
PR Newswire (US)

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

21 Noviembre 2024
PR Newswire (US)

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

18 Noviembre 2024
PR Newswire (US)

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 14, 2024 NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Gross...

14 Noviembre 2024
PR Newswire (US)

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

Initiating IND-enabling activities for MGX-001 development candidate (DC) in hemophilia A; Achieved durable Factor VIII activity levels over twelve months in nonhuman primate (NHP) study On track...

13 Noviembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Noviembre 2024
Edgar (US Regulatory)

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/...

11 Noviembre 2024
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.7723.33333333333.34.142.910122642613.66004254CS
42.14110.8808290161.934.921.8350052203.98775094CS
121.8482.51121076232.234.921.6118436543.70225475CS
260.5214.64788732393.555.49991.619435443.64342536CS
52-6.18-60.292682926810.2512.741.616114774.2575493CS
156-6.18-60.292682926810.2512.741.616114774.2575493CS
260-6.18-60.292682926810.2512.741.616114774.2575493CS

MGX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Metagenomi?
El precio actual de las acciones de Metagenomi es US$ 4.07
¿Cuántas acciones de Metagenomi están en circulación?
Metagenomi tiene 37,423,917 acciones en circulación
¿Cuál es la capitalización de mercado de Metagenomi?
La capitalización de mercado de Metagenomi es USD 151.57M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Metagenomi?
Metagenomi ha negociado en un rango de US$ 1.61 a US$ 12.74 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Metagenomi?
El ratio precio/beneficio de Metagenomi es -2.19
¿Cuál es el ratio de efectivo a ventas de Metagenomi?
El ratio de efectivo a ventas de Metagenomi es 3.34
¿Cuál es la moneda de reporte de Metagenomi?
Metagenomi presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Metagenomi?
El último ingresos anual de Metagenomi es USD 44.76M
¿Cuál es el último beneficio anual de Metagenomi?
El último beneficio anual de Metagenomi es USD -68.26M
¿Cuál es la dirección registrada de Metagenomi?
La dirección registrada de Metagenomi es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Metagenomi?
La dirección del sitio web de Metagenomi es www.metagenomi.co
¿En qué sector industrial opera Metagenomi?
Metagenomi opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DRCTDirect Digital Holdings Inc
US$ 5.25
(854.55%)
68.44M
CHEKCheck Cap Ltd
US$ 2.24
(279.66%)
40M
SLGLSol Gel Technologies Ltd
US$ 1.57
(265.97%)
18.17M
RELIReliance Global Group Inc
US$ 3.08
(156.67%)
105.54M
TRAWTraws Pharma Inc
US$ 12.50
(149.00%)
28.22M
AILEiLearningEngines Inc
US$ 0.199
(-77.51%)
29.66M
MGOLMGO Global Inc
US$ 0.4765
(-49.84%)
14.13M
YHCLQR House Inc
US$ 1.11
(-36.57%)
1.28M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4014
(-34.37%)
194.98M
ADGMAdagio Medical Holdings Inc
US$ 1.095
(-33.64%)
4.84M
EDBLEdible Garden AG Inc
US$ 0.3669
(54.35%)
407.91M
RGTIRigetti Computing Inc
US$ 10.945
(16.81%)
223.46M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4014
(-34.37%)
191.91M
NVDANVIDIA Corporation
US$ 139.67
(3.69%)
174.6M
RIMEAlgorhythm Holdings Inc
US$ 0.0925
(21.07%)
155.68M

MGX Discussion

Ver más
Landwehr Landwehr 2 días hace
There hasn't been any news in a while. However, the chart is looking really good
👍️0
Monksdream Monksdream 2 días hace
MGX under $5

[color=red][/color]
👍 1
Landwehr Landwehr 3 días hace
MGX still looking good. A mild new release will send this to 4.5. 
👍️0
TrendTrade2016 TrendTrade2016 5 días hace
GAVE IT A CHANCE...SOLD IT
👍️0
Landwehr Landwehr 5 días hace
We need a news release for this to go back up. I'm long on this stock 
👍️0
TrendTrade2016 TrendTrade2016 5 días hace
MGX GAPPING BACK UP...LAST ATTEMPT
👍️0
Landwehr Landwehr 6 días hace
If we can continue to consolidate and churn in this range for a few days we will be in good shape for the next news cycle. 
👍️0
TrendTrade2016 TrendTrade2016 6 días hace
5 DAY DOWN TREND SEEMS TO HAVE STOPPED
👍️0
Landwehr Landwehr 6 días hace
Very good consolidation while no new news
👍️0
TrendTrade2016 TrendTrade2016 6 días hace
MGX BUILDING A FOUNDATION
👍 1
Landwehr Landwehr 1 semana hace
The next news release will ignite this stock. 
👍️0
dinogreeves dinogreeves 1 semana hace
No, they are well funded well into 2025 and even beyond late 2025.
👍️0
Millenium323 Millenium323 1 semana hace
Bayer Healthcare bought a 10.8% stake in $MGX according to a Nov 6th filing. Bayer is a multibillion dollar company who is known for their Hemophilia Division. This happens to correspond to MGX's strength which is their Hemophilia pipeline

https://www.otcmarkets.com/filing/html?id=17946805&guid=3xY-kK_WErmSJth
👍 1
Landwehr Landwehr 1 semana hace
This is going to be a fun ride. Alot of volatility. It will get back close to 10 in the next couple months. Even if it's speculation 
👍️0
dinogreeves dinogreeves 2 semanas hace
I sold at $4.50.
👍️0
frans frans 2 semanas hace
MGX need money ???
👍️0
frans frans 2 semanas hace
MGX company work for MM not for shaholders and selling shares into market
👍️0
frans frans 2 semanas hace
all schort what I see on my L2 MM's 10 - 12 sametime
👍️0
theorysuit theorysuit 2 semanas hace
This is how these bios move. You get the early stage upwave which we are in. They will bring it down closer to commercialization again. Ride this upwave and expect periods of pullbacks and consolidation.
👍️0
Landwehr Landwehr 2 semanas hace
I wouldn't consider this stock a pump and dump. I do agree on the way to the 52 week low that shook alot of weak hands. Now with three sources of revenue and some of their products entering a new phase before production, this stock is getting noticed 
👍️0
frans frans 2 semanas hace
I am not out I am long
👍️0
theorysuit theorysuit 2 semanas hace
Stage 1 pump. They shook everyone out on the drive to 1.60. This is how stocks move.
👍️0
Landwehr Landwehr 2 semanas hace
A ride to $10
👍️0
frans frans 2 semanas hace
what is going on here ??
👍️0
TrendTrade2016 TrendTrade2016 2 semanas hace
MGX MONSTER
👍️0
dinogreeves dinogreeves 2 semanas hace
This is why it ran today with no news, someone knew it was coming

https://finance.yahoo.com/news/metagenomi-presents-updated-preclinical-data-021600360.html
👍️0
dinogreeves dinogreeves 2 semanas hace
Corporate presentation just an hour ago.

https://dbzipdrh8te83.cloudfront.net/MGX-ASH-December-2024.pdf
👍️0
dinogreeves dinogreeves 2 semanas hace
Great update! Hemophilia drug market was estimated to be 12.1 billion this year. 18.7 billion by 2034. I wonder how much they’ll charge for a cure….. or governments will pay for it. Amazing opportunity here. Stoked for the years ahead.
👍️0
dinogreeves dinogreeves 2 semanas hace
https://metagenomi.co/discovery-platform
👍️0
dinogreeves dinogreeves 2 semanas hace
This has 8-10 dollars written all over it in a week. Gene therapy is huge market, very huge.
👍️0
dinogreeves dinogreeves 2 semanas hace
Yup, this is real good one, I am still holding. Bought, then went out of the house to run errands. Over 7 dollars book value and revenues.
👍 1
Monksdream Monksdream 2 semanas hace
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock
👍️0
Monksdream Monksdream 2 semanas hace
UP OFF THE MAT, maybe it will grow legs
👍️0
Landwehr Landwehr 2 semanas hace
This could get to $5 this week
👍️0
glenn1919 glenn1919 2 semanas hace
MGX..................https://stockcharts.com/h-sc/ui?s=MGX&p=W&b=5&g=0&id=p86431144783
👍 1
eur06 eur06 2 semanas hace
Just got on line….it looks pretty good!!
Trying to get some.
👍️0
theorysuit theorysuit 2 semanas hace
LfG!
👍️0
dinogreeves dinogreeves 2 semanas hace
Will run to 10 dollars within a week. Insiders and Tutes bought above 10 dollars.
👍 1
TrendTrade2016 TrendTrade2016 2 semanas hace
mgx blowing up
👍️0
dinogreeves dinogreeves 2 semanas hace
1000% gains coming here, jumped in at 2.28 this morning with 4000 shares.
👍 1
KIPK KIPK 3 meses hace
POS ....You are
👍️0
KIPK KIPK 3 meses hace
You are a POS dude....
👍️0
theorysuit theorysuit 4 meses hace
Added again here in full size. Data looks fantastic.
👍️0
theorysuit theorysuit 4 meses hace
https://finance.yahoo.com/news/metagenomi-announces-preclinical-data-lead-200500503.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

Efficacy and Durability looks promising here. Lotto sized play here sub $3. I think Stage 1 Pump incoming. A deal to replace MRNA would be nice.
👍️0
theorysuit theorysuit 4 meses hace
buying in small chunks under $3.
👍️0
theorysuit theorysuit 4 meses hace
i'm buying it up as speculative play on cash value. Will hold a tight stop loss.
👍️0
theorysuit theorysuit 5 meses hace
every stock that i look into, you are here :)
👍️0
jondoeuk jondoeuk 8 meses hace
The IPO was way too early, and one of the few pillars of its business plan was the partnership. The fact that Moderna walked away means that has collapsed. In the future, IP could be another issue.
👍️0
jondoeuk jondoeuk 8 meses hace
Try not to end up being a bag holder for VC's shifting overvalued ''dream companies.''
👍️0
jondoeuk jondoeuk 8 meses hace
MRNA walks away from the deal that could have generated up to $3B, handing back full global rights and related technologies.
👍️0

Su Consulta Reciente

NASDAQ
MGX
Metagenomi
BIT
SRIJ
Bnp Paribas Easy Msci Ja...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados